Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

Angela R Branche; Nadine G Rouphael; Cecilia Losada; Lindsey R Baden; Evan J Anderson; Anne F Luetkemeyer; David J Diemert; Patricia L Winokur; Rachel M Presti; Angelica C Kottkamp; Ann R Falsey; Sharon E Frey; Richard Rupp; Martín Bäcker; Richard M Novak; Emmanuel B Walter; Lisa A Jackson; Susan J Little; Lilly C Immergluck; Siham M Mahgoub; Jennifer A Whitaker; Tara M Babu; Paul A Goepfert; Dahlene N Fusco; Robert L Atmar; Christine M Posavad; Antonia Netzl; Derek J Smith; Kalyani Telu; Jinjian Mu; Mat Makowski; Mamodikoe K Makhene; Sonja Crandon; David C Montefiori; Paul C Roberts; John H Beigel

Clinical Infectious Diseases (2023) - Comments
doi: 10.1093/cid/ciad209 issn: 1058-4838 issn: 1537-6591 pubmed: 37036397

Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, Anne F Luetkemeyer, David J Diemert, Patricia L Winokur, Rachel M Presti, Angelica C Kottkamp, Ann R Falsey, Sharon E Frey, Richard Rupp, Martín Bäcker, Richard M Novak, Emmanuel B Walter, Lisa A Jackson, Susan J Little, Lilly C Immergluck, Siham M Mahgoub

Go to article
Go to preprint

Oxford University Press (OUP)